Tens of thousands of medical tests to now fall under federal oversight
The Food and Drug Administration (FDA) is revising long-standing rules to place laboratory tests under the same jurisdiction as other testing, which the agency says will help ensure better safety and efficacy.
Since 1976, the FDA has not enforced legal requirements on most laboratory developed tests (LDT) due to the Medical Device Amendments. Generally speaking, this has meant that requirements such as good manufacturing practices, premarket reviews prior to use in patients and adverse event reporting has not been enforced.
LDTs are diagnostic tests that are made and used within a single laboratory. As the FDA noted in its rule Monday, LDTs were typically manufactured in small volumes to diagnose rare diseases. At the time, the FDA's rationale for not enforcing regulations on these tests were that they were low-risk and were employed for a small patient population.
But LDTs have grown in use over the years, as have concerns over their lack of regulatory oversight. Common LDTs today include tests for COVID-19, blood level tests and tests for drug abuse. While LDTs in the '70's were carried out by laboratory personnel with expertise, current-day tests now use high-tech instrumentation and software to generate results.
"Today’s LDTs are also more commonly manufactured with instruments or other components not legally marketed for clinical use and are more often used to inform or direct critical treatment decisions, to widely screen for common diseases, to predict personal risk of developing certain diseases, and to diagnose serious medical conditions such as cancer and heart disease," the FDA said in its final rule on LDTs.
The FDA cited these factors when announcing the change.
“LDTs are being used more widely than ever before — for use in newborn screening, to help predict a person’s risk of cancer, or aid in diagnosing heart disease and Alzheimer’s. The agency cannot stand by while Americans continue to rely on results of these tests without assurance that they work," FDA Commissioner Robert M. Califf said in a statement.
The announcement was welcomed by health groups.
The American Cancer Society called the change "a positive step toward ensuring uniform review of all tests intended for the same purpose."
The move also drew some blowback, however. Sen. Bill Cassidy (R-La.), ranking member of the Senate Committee on Health, Education, Labor and Pensions, blasted the decision.
"The FDA does not have the authority to unilaterally increase its regulatory jurisdiction. This rule will undermine access to essential laboratory tests, increase health care costs, and ultimately harm patients," Cassidy said in a statement.
"During the pandemic, we saw how too much government interference and red tape delays lifesaving care to Americans. Congress needs to take action to clarify the regulatory structure for diagnostic tests.”
Date: |
Filter
-
Ten Hag: 'Example' Fernandes wanted at Man Utd
Erik ten Hag assured Bruno Fernandes that Manchester United want to keep him this summer after the Portugal midfielder said he will only stay if he feels wanted at Old Trafford.ESPN - Sports -
The church of Warren Buffett: Why thousands of investors flock to Omaha to be near the investing genius
Tens of thousands of investors attended the Berkshire Hathaway shareholders meeting in Omaha, Nebraska this year. I went to see what they were all doing there.CNBC - Business -
Colossal wildfires burn across Canada, driving thousands of people to evacuate with kids, pets and precious belongings
Yahoo News - World -
Under Armour to Slash Jobs, Warns of Revenue Drop
CEO Kevin Plank said the sportswear brand has tried to do “too much of too much” and will focus on selling fewer products on discounts.The Wall Street Journal - World -
Medical examiner links spicy tortilla chips to death of Massachusetts teen who took part in social media challenge
Medical examiner links spicy tortilla chips to death of Massachusetts teen who took part in social media challengeABC News - Health -
South Korean court rejects effort to block plan that would boost medical school admissions
A South Korean court has ruled in favor of the government’s contentious plan to drastically boost medical school admissionsABC News - Health - South Korea -
Yonhap news agency says Seoul court has ruled in favor of the government’s plan to boost medical school admissions
Yonhap news agency says Seoul court has ruled in favor of the government’s plan to boost medical school admissionsABC News - Health -
Boy, 5, dies in fall from block of flats
A neighbour says the boy's parents are "inconsolable" after his death in east London.BBC News - Top stories
More from The Hill
-
Biden announces 'major step' toward reclassifying marijuana
The Biden administration announced Thursday it had initiated the formal rulemaking process to reschedule marijuana to Schedule III from its Schedule I designation that it has held for over 50 years. This announcement follows the Department of ...The Hill - Politics - Joe Biden -
Who are Trump's top VP contenders?
Welcome to The Hill's Campaign newsletter {beacon} Campaign Report Campaign Report The Big Story Who are Trump's top VP contenders? The veepstakes for former President Trump seems to be picking up, with several of the top choices to be the ...The Hill - Politics - Donald Trump -
Kerry Washington, Adam Kinzinger to help lead poll worker recruitment effort
Kerry Washington and former Rep. Adam Kinzinger (R-Ill.) are teaming up to help lead an effort to recruit election poll workers ahead of November. The former "Scandal" star and the ex-congressman will be among the co-chairs on an advisory council ...The Hill - Politics -
CAIR condemns GOP call to probe finances of student protesters
The Council on American-Islamic Relations (CAIR) is calling out House Republicans over their request for the Treasury Department to investigate the finances of the pro-Palestinian student protesters who have set up encampments at scores of U.S. ...The Hill - Politics -
Democrats cheer after Supreme Court rejects challenge to consumer bureau
Democrats and financial industry critics celebrated Wednesday after the Supreme Court rejected a challenge to the Consumer Financial Protection Bureau's (CFPB) funding structure. “The United States Supreme Court follow the law, and the CFPB is ...The Hill - Politics